Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Air Water Inc. (4088.T)
Osaka, JP
Air Water Inc., established in 1929 and headquartered in Osaka, Japan, is a diversified conglomerate operating across numerous sectors including industrial gas, chemicals, medical products, energy, agriculture, and food. Its industrial gas division produces and supplies a range of atmospheric and specialty gases, such as oxygen, nitrogen, argon, carbon dioxide, hydrogen, and helium. This segment also delivers air separation systems, gas handling equipment, argon-based shielding gases, special gases, and comprehensive engineering solutions. The chemicals sector provides quinone, organic acids, fine chemicals, and custom synthesis services. It also develops pharmaceutical and agricultural chemical intermediates, electronic materials, printed circuit boards, and various carbon-based materials. In healthcare, Air Water Inc. offers medical oxygen, nitric oxide, and liquefied helium. It manages hospital facilities and provides a wide array of medical equipment, such as endoscope systems, hyperbaric oxygen chambers, respiratory support devices, and surgical instruments. The company further extends its medical services to include supply chain management, instrument sterilization, and consumer-focused products like oxygen concentrators, infusion pumps, hygiene materials, injection needles, dental technology, and nursing care items. The energy business distributes liquefied petroleum (LP) gas, kerosene, and natural gas (LNG). It also supplies various household and commercial energy appliances, including water heaters, stoves, boilers, kitchen systems, toilets, unit baths, garages, and carports. Specialized transport equipment like LP gas-type mobile power source vehicles, LNG transport equipment, and fuel lorries are also part of its offerings. Within agriculture and food products, the company provides a wide selection of items from hams and sausages to frozen foods, sweets, fresh vegetables, and beverages (soft drinks, vegetable, and fruit). It also manufactures agricultural machinery and offers wholesale, processing, and retail services for fruits and vegetables. Additionally, Air Water Inc. provides comprehensive logistics services, encompassing high-pressure gas, general cargo, food transport, and bodywork. Its remaining portfolio features salt, environmental solutions, seaweed and adsorbent products, electricity supply, magnesia, aerosol products, electronic materials, phenolic resins, O-rings, metal surface treatment services, artificial recycled wood, SiC substrates, and various engineering services.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.48% | +8.78% | -8.03% | -18.56% | -10.61% | -9.13% | +2.16% | +12.60% | +15.05% | +21.87% | +436.81% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+5.0% ★ Q3'25: +0.9% (vs Q3'24)
-
EPS growth Chemicals - Specialty: +13.2%+10.2% Q3'25: -507.7% (vs Q3'24)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+3.1% ★ Q3'25: +3.2% (vs Q3'24)
-
EBIT margin Chemicals - Specialty: +8.8%+6.0% Q3'25: +5.4% (vs Q3'24)
-
ROIC Chemicals - Specialty: +5.6%+4.9% Q3'25: +6.6% (vs Q3'24)
-
Share dilution Chemicals - Specialty: +0.1%+0.4% Q3'25: +0.2% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.87× Q3'25: 3.89× (vs Q3'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 4 Rev. Ana. 3 EPS Ana. |
Mar 2027 4 Rev. Ana. 3 EPS Ana. |
Mar 2028 3 Rev. Ana. 3 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
660.54B
est: 668.80B (-1.2%)
|
660.62B
est: 674.50B (-2.1%)
|
670.54B
est: 682.92B (-1.8%)
|
753.56B
est: 750.98B (+0.3%)
|
742.29B
est: 803.33B (-7.6%)
|
809.08B
est: 817.31B (-1.0%)
|
806.63B
est: 812.83B (-0.8%)
|
888.67B
est: 886.88B (+0.2%)
|
1.00T
est: 996.00B (+0.9%)
|
1.02T
est: 1.04T (-1.5%)
|
1.08T
est: 1.09T (-1.4%)
|
1.17T
1.16T – 1.18T
+7.2% YoY
|
1.23T
1.22T – 1.25T
+5.5% YoY
|
1.28T
1.27T – 1.29T
+3.7% YoY
|
1.36T
1.34T – 1.38T
+6.3% YoY
|
1.46T
1.44T – 1.48T
+7.4% YoY
|
| EBITDA |
63.46B
est: 75.67B (-16.1%)
|
68.43B
est: 76.31B (-10.3%)
|
69.32B
est: 77.27B (-10.3%)
|
72.06B
est: 84.96B (-15.2%)
|
74.43B
est: 90.89B (-18.1%)
|
81.07B
est: 92.47B (-12.3%)
|
84.53B
est: 91.96B (-8.1%)
|
102.79B
est: 100.34B (+2.4%)
|
94.69B
est: 112.69B (-16.0%)
|
108.45B
est: 109.56B (-1.0%)
|
113.99B
est: 114.89B (-0.8%)
|
123.20B
121.64B – 124.49B
+7.2% YoY
|
129.94B
128.49B – 131.44B
+5.5% YoY
|
134.78B
133.82B – 135.75B
+3.7% YoY
|
143.20B
141.61B – 144.86B
+6.2% YoY
|
153.73B
152.02B – 155.51B
+7.4% YoY
|
| EBIT |
36.13B
est: 44.47B (-18.8%)
|
39.52B
est: 44.85B (-11.9%)
|
41.34B
est: 45.41B (-9.0%)
|
42.40B
est: 49.94B (-15.1%)
|
43.65B
est: 53.42B (-18.3%)
|
46.08B
est: 54.35B (-15.2%)
|
45.50B
est: 54.05B (-15.8%)
|
59.41B
est: 58.98B (+0.7%)
|
49.71B
est: 66.23B (-25.0%)
|
61.86B
est: 63.17B (-2.1%)
|
64.76B
est: 66.25B (-2.2%)
|
71.04B
70.14B – 71.79B
+7.2% YoY
|
74.93B
74.09B – 75.79B
+5.5% YoY
|
77.72B
77.16B – 78.28B
+3.7% YoY
|
82.58B
81.66B – 83.53B
+6.3% YoY
|
88.65B
87.66B – 89.67B
+7.4% YoY
|
| Net Income |
20.70B
est: 24.93B (-17.0%)
|
20.14B
est: 25.28B (-20.3%)
|
22.34B
est: 27.98B (-20.2%)
|
25.17B
est: 30.13B (-16.5%)
|
28.82B
est: 31.77B (-9.3%)
|
30.43B
est: 32.08B (-5.1%)
|
27.37B
est: 30.19B (-9.3%)
|
43.22B
est: 42.76B (+1.1%)
|
40.14B
est: 39.50B (+1.6%)
|
44.36B
est: 46.59B (-4.8%)
|
49.08B
est: 49.40B (-0.7%)
|
21.77B
21.73B – 21.81B
-55.9% YoY
|
49.47B
48.80B – 50.13B
+127.2% YoY
|
63.57B
63.52B – 64.61B
+28.5% YoY
|
70.44B
69.40B – 71.47B
+10.8% YoY
|
79.98B
78.82B – 81.18B
+13.6% YoY
|
| SGA |
81.29B
est: 95.44B (-14.8%)
|
88.24B
est: 96.25B (-8.3%)
|
101.43B
est: 97.45B (+4.1%)
|
107.26B
est: 107.16B (+0.1%)
|
117.32B
est: 114.63B (+2.3%)
|
123.41B
est: 116.63B (+5.8%)
|
121.43B
est: 115.99B (+4.7%)
|
125.54B
est: 126.56B (-0.8%)
|
135.01B
est: 142.13B (-5.0%)
|
141.76B
est: 146.34B (-3.1%)
|
149.24B
est: 153.46B (-2.7%)
|
164.56B
162.48B – 166.28B
+7.2% YoY
|
173.56B
171.62B – 175.56B
+5.5% YoY
|
180.03B
178.74B – 181.32B
+3.7% YoY
|
191.28B
189.15B – 193.49B
+6.3% YoY
|
205.34B
203.06B – 207.72B
+7.4% YoY
|
| EPS |
105.74
est: 108.95 (-2.9%)
|
102.73
est: 110.46 (-7.0%)
|
114.53
est: 122.28 (-6.3%)
|
128.95
est: 131.67 (-2.1%)
|
147.33
est: 138.84 (+6.1%)
|
147.43
est: 140.17 (+5.2%)
|
120.97
est: 131.92 (-8.3%)
|
191.06
est: 186.87 (+2.2%)
|
176.84
est: 175.11 (+1.0%)
|
194.68
est: 204.29 (-4.7%)
|
214.57
est: 215.82 (-0.6%)
|
95.13
94.94 – 95.30
-55.9% YoY
|
216.88
213.26 – 219.05
+128.0% YoY
|
280.60
277.58 – 282.33
+29.4% YoY
|
307.70
303.24 – 312.32
+9.7% YoY
|
349.50
344.44 – 354.75
+13.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Pan Asia Dividend Aristocrats UCITS ETF (Dist) ASDV.L | 0.71% | 1.72M | 0.55% |
| 2 | iShares MSCI Japan Small-Cap ETF SCJ | 0.21% | 532.9K | 0.50% |
| 3 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.21% | 1.17M | 0.58% |
| 4 | Avantis International Small Cap Value ETF AVDV | 0.17% | 33.15M | 0.36% |
| 5 | Avantis Global Small Cap Value UCITS ETF AVGS.L | 0.12% | 1.31M | 0.39% |
| 6 | Avantis International Small Cap Equity ETF AVDS | 0.11% | 360.1K | 0.30% |
| 7 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD acc WSCSRI.SW | 0.10% | 837.0K | 0.23% |
| 8 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD dis WSCR.L | 0.10% | 836.6K | 0.23% |
| 9 | Xtrackers FTSE Developed ex US Multifactor ETF DEEF | 0.09% | 50.3K | 0.24% |
| 10 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.08% | 175.2K | 0.83% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ryosuke Matsubayashi | COO, CEO, President & Representative Director | 114M | male |
| Hidetoshi Onoe | Sr Mag. Exe. Off., Head of Health & Safety Group, Head of Dental Care Unit and Corporate Director | — | male |
| Kikue Inoue | Executive Officer & Director | — | female |
| Shigeki Otsuka | Sr. Managing Exe. Off., Corp. Director and GM of Financial & Investor Relations Strategy Office | — | male |
| Yoshito Mashiko | Sales Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4088.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
